What is Coyote Stone?
Coyote Stone operates at the intersection of patient-centric care and clinical infrastructure, providing a comprehensive suite of durable medical equipment (DME) and laboratory services. By bridging the gap between wholesale medical supply and personalized patient instruction, the company addresses critical inefficiencies in the healthcare supply chain. Their business model is designed to support both individual patients and large-scale medical facilities, offering integrated billing solutions and logistical support that streamline the procurement of essential medical hardware. This dual-focus strategy allows Coyote Stone to maintain a competitive edge in a fragmented market, ensuring that both clinical providers and end-users receive high-touch service alongside reliable product delivery.
How much funding has Coyote Stone raised?
Coyote Stone has raised a total of $181K across 1 funding round:
Debt
$181K
Debt (2021): $181K with participation from PPP
Key Investors in Coyote Stone
PPP
Public-Private Partnership
What's next for Coyote Stone?
With the recent influx of capital, Coyote Stone is well-positioned to scale its operational footprint and enhance its technological infrastructure. The company is expected to prioritize the expansion of its wholesale distribution network and the optimization of its billing platforms, which are essential for maintaining long-term profitability in the DME space. As the healthcare industry continues to shift toward integrated service models, Coyote Stone's ability to provide end-to-end support—from product procurement to patient education—will likely serve as a primary driver for future growth. Management will likely focus on deepening relationships with clinical partners to capture a larger share of the institutional supply market, thereby reinforcing its status as a critical node in the medical services value chain.
See full Coyote Stone company page
